Medicus Pharma Ltd.
SEC CIK 1997296 · MDCX · last insider filing 2026-06-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mahaffy Patrick J | Director | filed 2025–2026 |
| Ashton William | Director | filed 2024–2026 |
| Bokhari Raza | Director · Chief Executive Officer | filed 2024–2026 |
| Fishman Barry | Director | filed 2024–2026 |
| Ciaruffoli Robert J. | Director | filed 2024–2026 |
| Kaiser Larry | Director | filed 2024–2026 |
| May Sara R. | Director | filed 2024–2026 |
| Raju Ajay | Director | filed 2024–2026 |
| Rodgers Cathy Mcmorris | Director | filed 2025–2026 |
| Lavelle Frank W | Director | filed 2024–2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Smith Andrew Alasdair | Chief Operating Officer | filed 2025–2026 |
| Bonner Carolyn F. | President and CFO | filed 2024–2026 |
| Mehmud Faisal | Chief Medical Officer | filed 2024–2026 |
| Brennan Edward J. | Chief Scientific Officer | filed 2024–2026 |
| Quinlan James P. | Chief Financial Officer | filed 2024–2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.